Mason and colleagues (2010) 12 reported that for the period 2004 2008, the STA process had not shortened the timelines compared to MTAs, for cancer drugs, but did not examine non-cancer medications.
Italy took part in this study, but with different timelines compared to other countries, because Italian Investigators added an additional sub-study to assess body composition with bioelectrical impedance analysis (BIA).
Creators suggest the single time line Ruka was male, is the anomaly specific to Ruka alone, suggesting Ruka could have possibly been in the incorrect timeline compared to the others, thus the concept of changing the mothers diet from meat to vegetables having no scientific support that it can alter a fetus' sex outcome in any way confirms, Ruka was in the wrong timeline from the beginning.
Direct reprogramming as an alternative to deriving human iPSCs offers the advantage of a 2-week timeline, compared to 2 3 months (Table 1).
The whole point of SolarCity's approach is to lower some of the barriers to solar adoption for everyday homeowners, by creating a product that has a similar installation process and timeline when compared to traditional roofs, as well as a look that is not out-of-place or otherwise unattractive.
China and India have established a precedent of demanding greater leeway and extended timelines for compliance as compared to the already industrialized.
Fig. 3 Timeline of trauma resuscitation for our case compared to an ideal resuscitation timeline.
The 24-hour trend of the noise level was obtained for the patients of length-of-stay (LOS) ≥1 day, which was compared to the timeline of the ICU routine events.
For the occupational intervention, process evaluation will include the timeline of the process as compared to the protocol, the number of workplace visits in relation to the number indicated, and the degree to which planned workplace adaptations are implemented (a score from 0 to 10).
Equally striking has been the rapid development of targeted therapies compared to the timeline for cytotoxic therapies, best exemplified by the development of ALK inhibitors for lung cancer, which took less than 5 years from initial identification of the EML4-ALK rearrangement as a molecular biomarker to clinical approval of the drug.
The project, which will involve both private and public institutions, does not yet outline specific goals or a timeline, but its scope has been compared to that of the Human Genome Project.
